Works matching DE "BLOOD coagulation factor XIIIa"

Results: 13

Clinical value of exogenous factor XIII for prolonged air leak following pulmonary lobectomy: a case control study.

Published in:

BMC Surgery, 2014, v. 14, n. 1, p. 85, doi. 10.1186/1471-2482-14-109

By:

Hidetoshi Inoue;
Noritoshi Nishiyama;
Shinjiro Mizuguchi;
Koshi Nagano;
Nobuhiro Izumi;
Hiroaki Komatsu;
Shigefumi Suehiro

Publication type:

Article

Blood coagulation factor XIII-A subunit Val34Leu polymorphisms and intracerebral hemorrhage risk: A meta-analysis of case-control studies.

Published in:

British Journal of Neurosurgery, 2015, v. 29, n. 5, p. 672, doi. 10.3109/02688697.2015.1054344

By:

Ma, Junpeng;
Li, Hao;
You, Chao;
Liu, Yi;
Ma, Lu;
Huang, Siqing

Publication type:

Article

Evaluation and comparison of staining patterns of factor XIIIa ( AC-1A1), adipophilin and GATA3 in sebaceous neoplasia.

Published in:

Journal of Cutaneous Pathology, 2018, v. 45, n. 1, p. 1, doi. 10.1111/cup.13037

By:

Tjarks, Brian J.;
Pownell, Brandy R.;
Evans, Claire;
Thompson, Paul A.;
Kerkvliet, Amy M.;
Koch, Michael R. D.;
Jassim, Ali D.

Publication type:

Article

Immunohistochemical markers informing the diagnosis of sebaceous carcinoma and its distinction from its mimics: Adipophilin and factor XIIIa to the rescue?

Published in:

Journal of Cutaneous Pathology, 2018, v. 45, n. 1, p. 29, doi. 10.1111/cup.13073

By:

Tetzlaff, Michael T.

Publication type:

Article

Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms.

Published in:

Journal of Cutaneous Pathology, 2016, v. 43, n. 8, p. 649, doi. 10.1111/cup.12726

By:

Uhlenhake, Elizabeth E.;
Clark, Lindsey N.;
Smoller, Bruce R.;
Shalin, Sara C.;
Gardner, Jerad M.

Publication type:

Article

Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytes.

Published in:

Journal of Cutaneous Pathology, 2016, v. 43, n. 8, p. 657, doi. 10.1111/cup.12727

By:

Clark, Lindsey N.;
Elwood, Hillary R.;
Uhlenhake, Elizabeth E.;
Smoller, Bruce R.;
Shalin, Sara C.;
Gardner, Jerad M.

Publication type:

Article

Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?

Published in:

Journal of Blood Medicine, 2014, v. 5, p. 107, doi. 10.2147/JBM.S35395

By:

Korte, Wolfgang

Publication type:

Article

Dímero D: utilidad diagnóstica y aplicación en la clínica.

Published in:

Revista Médica de Risaralda, 2010, v. 16, n. 2, p. 57

By:

Rosero, Harold Miranda;
Blanco, José Luis;
Cárdenas, Kenny Mauricio Gálvez

Publication type:

Article

Free factor XIII activation peptide ( fAP- FXIII) is a regulator of factor XIII activity via factor XIII-B.

Published in:

British Journal of Haematology, 2016, v. 172, n. 3, p. 452, doi. 10.1111/bjh.13835

By:

Dodt, Johannes;
Pasternack, Ralf;
Seitz, Rainer;
Volkers, Peter

Publication type:

Article

Substrates of Factor XIII-A: roles in thrombosis and wound healing.

Published in:

Clinical Science, 2013, v. 124, n. 3, p. 123, doi. 10.1042/CS20120233

By:

RICHARDSON, Victoria R.;
CORDELL, Paul;
STANDEVEN, Kristina F.;
CARTER, Angela M.

Publication type:

Article

New Infestin-4 Mutants with Increased Selectivity against Factor XIIa.

Published in:

PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144940

By:

Kolyadko, Vladimir N.;
Lushchekina, Sofya V.;
Vuimo, Tatiana A.;
Surov, Stepan S.;
Ovsepyan, Ruzanna A.;
Korneeva, Vera A.;
Vorobiev, Ivan I.;
Orlova, Nadezhda A.;
Minakhin, Leonid;
Kuznedelov, Konstantin;
Severinov, Konstantin V.;
Ataullakhanov, Fazoil I.;
Panteleev, Mikhail A.

Publication type:

Article

Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis.

Published in:

Haemophilia, 2013, v. 19, n. 2, p. e93, doi. 10.1111/hae.12069

By:

Ngo Sack, F.;
Galinat, H.;
Egreteau, P.‐Y.;
Mollard, L. M.;
Fortin, H.;
Berthou, C.;
Abgrall, J. F.;
Pan‐Petesch, B.

Publication type:

Article

Absorption, metabolism and excretion of darexaban (YM150), a new direct factor Xa inhibitor in humans.

Published in:

Xenobiotica, 2013, v. 43, n. 6, p. 534, doi. 10.3109/00498254.2012.738045

By:

Hashimoto, Tadashi;
Suzuki, Katsuhiro;
Kihara, Yukie;
Iwatsubo, Takafumi;
Miyashita, Aiji;
Heeringa, Marten;
Onkels, Hartmut;
Groenendaal, Dorien;
Verheggen, Frank;
van Marle, Sjoerd;
Usui, Takashi

Publication type:

Article